T3 Pharma is a Swiss biotech company developing highly innovative cancer treatments based on live bacteria.

Basel, Switzerland
Joined September 2019
#NEWS: We are acquiring T3 Pharmaceuticals aiming to cure cancers and transform lives through science. Learn more about how we will realize the full potential of this novel cancer therapy platform: bit.ly/47BJHjm #ResearchCollaboration #ImmunoOncology #Cancer
9
1
32
5,444
Happy to share that we have received funding by the Swiss Accelerator. We are honored and extremely proud to be among these highly innovative companies! Thank you @Innosuisse for trusting in T3 Pharma's team and our bacterial cancer therapy platform. innosuisse.ch/inno/en/home/m…
1
582
T3 Pharma has been awarded the SEF award 2021 in the category High-tech/Biotech!!! We are extremely proud to have been selected by the jury for such prestigious price. #SEF21 #SEFaward21
3
1
7
T3 Pharma in the final of the Swiss Economic Award 2021! We are proud to be able to pitch at the Swiss Economic Forum on 1/2 September in Interlaken and ultimately hope for first place. More at swisseconomic.ch/en/swiss-ec… #SEFAward21 #SEF21
2
6
Today we raised a 25M CHF #FinancingRound from existing investors: @Boehringer Ingelheim Venture Fund, #ReferenceCapital SA, #Wille Finance AG and private investors. This will support #ClinicalTrials for our lead candidate, T3P-Y058-739, to treat #SolidTumors.
2
2
8
T3 Pharma closes its second financing round with existing investors joined by «Boehringer Ingelheim Venture Fund» and «Reference Capital SA». Furthermore, we are delighted to welcome Claire Barton as Chief Medical Officer and to announce our clinical advisory board.
1
3